Home » Emerging Therapeutic Options for Medullary Thyroid Cancer and Differentiated Thyroid Cancer
Emerging Therapeutic Options for Medullary Thyroid Cancer and Differentiated Thyroid Cancer
Co-provided by: A. Webb Roberts Center for CME of Baylor Health Care System and CancerNet.
This activity is supported by independent educational grants from AstraZeneca, and Genzyme, a Sanofi company.
Release date: June 6, 2014
Valid through: June 6, 2015
This webcast is designed to meet the educational needs of medical oncologists and other health care professionals who diagnose, treat, and manage patients with thyroid cancer.
This webcast is intended to improve care of patients with thyroid cancer by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. This Internet CME activity is designed to provide clinical decision-making strategies for integration of novel therapeutic options.
This program consists of 2 continuing education activites.